Please enable JavaScript to continue using this application.

Compare $MEDP vs $TECH | Chartloom

Compare

$MEDP vs $TECH

Medpace Holdings Inc · Bio-Techne Corp

MEDP

Medpace Holdings Inc

TECH

Bio-Techne Corp

Compare $MEDP vs $TECH

Comparing Medpace Holdings Inc and Bio-Techne Corp

MEDPMedpace Holdings Inc

TECHBio-Techne Corp

MEDPMedpace Holdings Inc

Market cap

$17.08B

P/E (TTM)

35.56x

Forward P/E (NTM)

32.69x

Forward P/S (NTM)

5.76x

Rev growth (TTM)

24.7%

YTD performance

7.2%

52W performance

15.3%

FCF yield

4.1%

TECHBio-Techne Corp

Market cap

$11.29B

P/E (TTM)

62.64x

Forward P/E (NTM)

34.64x

Forward P/S (NTM)

8.77x

Rev growth (TTM)

-0.4%

YTD performance

21.5%

52W performance

19.6%

FCF yield

2.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MEDP

TECH

Detailed metrics comparison

MEDP

Medpace Holdings Inc

TECH

Bio-Techne Corp

Market Cap

MEDP$17.08B

TECH$11.29B

Enterprise Value

MEDP$16.58B

TECH$11.23B

Price

MEDP$612.05

TECH$72.46

P/E Ratio

MEDP35.56x

TECH62.64x

P/S Ratio

MEDP6.14x

TECH9.29x

EV/Sales

MEDP5.96x

TECH9.24x

EV/EBITDA

MEDP27.13x

TECH28.63x

P/B Ratio

MEDP38.57x

TECH5.39x

P/FCF Ratio

MEDP24.17x

TECH42.89x

EV/FCF

MEDP23.46x

TECH42.65x

PEG Ratio

MEDP2.97x

TECH9.81x

Forward P/E (NTM)

MEDP32.69x

TECH34.64x

Forward P/S (NTM)

MEDP5.76x

TECH8.77x

Revenue (TTM)

MEDP$2.78B

TECH$1.22B

Revenue Growth (YoY)

MEDP24.7%

TECH-0.4%

Forward Rev Growth

MEDP6.2%

TECH9.8%

Gross Margin (TTM)

MEDP28.8%

TECH66.2%

Operating Margin (TTM)

MEDP21.0%

TECH20.7%

EBITDA Margin (TTM)

MEDP22.0%

TECH31.6%

Net Margin (TTM)

MEDP17.7%

TECH15.0%

FCF Margin (TTM)

MEDP25.4%

TECH21.7%

Net Income (TTM)

MEDP$492M

TECH$182M

FCF (TTM)

MEDP$707M

TECH$263M

EPS (TTM)

MEDP$17.21

TECH$1.16

ROE (TTM)

MEDP110.1%

TECH8.9%

ROA (TTM)

MEDP24.8%

TECH7.1%

ROIC (TTM)

MEDP110.1%

TECH8.0%

Cash

MEDP$503M

TECH$265M

Debt

MEDP$0

TECH$200M

Net Cash/Debt

MEDP$503M

TECH$65M

Current Ratio (TTM)

MEDP0.73x

TECH4.55x

Quick Ratio (TTM)

MEDP0.66x

TECH3.35x

Debt/Equity (TTM)

MEDP0.00x

TECH0.09x

Debt/Assets (TTM)

MEDP0.0%

TECH0.0%

Interest Coverage (TTM)

MEDPN/A

TECHN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

TECH0.00x

Beta

MEDP1.11

TECH1.29

52W Performance

MEDP15.3%

TECH19.6%

YTD Performance

MEDP7.2%

TECH21.5%

% from 52W High

MEDP-9.7%

TECH-0.3%

% from 52W Low

MEDP64.1%

TECH67.7%

Asset Turnover (TTM)

MEDP1.41x

TECH0.48x

FCF Yield (TTM)

MEDP4.1%

TECH2.3%

Earnings Yield (TTM)

MEDP2.9%

TECH1.6%

Dividend Yield (TTM)

MEDPN/A

TECH0.4%

Rule of 40

MEDP50.1

TECH21.3

EV/GP/RG

MEDP3.15

TECH2.28

Ticker research

View MEDP research View TECH research

Metric	MEDP Medpace Holdings Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$17.08B	$11.29B
Enterprise Value	$16.58B	$11.23B
Price	$612.05	$72.46
P/E Ratio	35.56x	62.64x
P/S Ratio	6.14x	9.29x
EV/Sales	5.96x	9.24x
EV/EBITDA	27.13x	28.63x
P/B Ratio	38.57x	5.39x
P/FCF Ratio	24.17x	42.89x
EV/FCF	23.46x	42.65x
PEG Ratio	2.97x	9.81x
Forward P/E (NTM)	32.69x	34.64x
Forward P/S (NTM)	5.76x	8.77x
Revenue & Growth
Revenue (TTM)	$2.78B	$1.22B
Revenue Growth (YoY)	24.7%	-0.4%
Forward Rev Growth	6.2%	9.8%
Profitability
Gross Margin (TTM)	28.8%	66.2%
Operating Margin (TTM)	21.0%	20.7%
EBITDA Margin (TTM)	22.0%	31.6%
Net Margin (TTM)	17.7%	15.0%
FCF Margin (TTM)	25.4%	21.7%
Net Income (TTM)	$492M	$182M
FCF (TTM)	$707M	$263M
EPS (TTM)	$17.21	$1.16
ROE (TTM)	110.1%	8.9%
ROA (TTM)	24.8%	7.1%
ROIC (TTM)	110.1%	8.0%
Financial Health
Cash	$503M	$265M
Debt	$0	$200M
Net Cash/Debt	$503M	$65M
Current Ratio (TTM)	0.73x	4.55x
Quick Ratio (TTM)	0.66x	3.35x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.29
52W Performance	15.3%	19.6%
YTD Performance	7.2%	21.5%
% from 52W High	-9.7%	-0.3%
% from 52W Low	64.1%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.48x
FCF Yield (TTM)	4.1%	2.3%
Earnings Yield (TTM)	2.9%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	50.1	21.3
EV/GP/RG	3.15	2.28
Ticker research	View MEDP research	View TECH research

Valuation

P/E Ratio

MEDP

35.56x

TECH

62.64x

P/S Ratio

MEDP

6.14x

TECH

9.29x

EV/FCF

MEDP

23.46x

TECH

42.65x

Growth & revenue

Revenue Growth TTM

MEDP

24.7%

TECH

-0.4%

Forward Revenue Growth

TECH

9.8%

MEDP

6.2%

Profitability & performance

Gross Margin

TECH

66.2%

MEDP

28.8%

ROE

MEDP

110.1%

TECH

8.9%

FCF Yield %

MEDP

4.1%

TECH

2.3%

52-Week Performance

TECH

19.6%

MEDP

15.3%

Detailed metrics comparison

MEDP

Medpace Holdings Inc

TECH

Bio-Techne Corp

Market Cap

MEDP$17.08B

TECH$11.29B

Enterprise Value

MEDP$16.58B

TECH$11.23B

Price

MEDP$612.05

TECH$72.46

P/E Ratio

MEDP35.56x

TECH62.64x

P/S Ratio

MEDP6.14x

TECH9.29x

EV/Sales

MEDP5.96x

TECH9.24x

EV/EBITDA

MEDP27.13x

TECH28.63x

P/B Ratio

MEDP38.57x

TECH5.39x

P/FCF Ratio

MEDP24.17x

TECH42.89x

EV/FCF

MEDP23.46x

TECH42.65x

PEG Ratio

MEDP2.97x

TECH9.81x

Forward P/E (NTM)

MEDP32.69x

TECH34.64x

Forward P/S (NTM)

MEDP5.76x

TECH8.77x

Revenue (TTM)

MEDP$2.78B

TECH$1.22B

Revenue Growth (YoY)

MEDP24.7%

TECH-0.4%

Forward Rev Growth

MEDP6.2%

TECH9.8%

Gross Margin (TTM)

MEDP28.8%

TECH66.2%

Operating Margin (TTM)

MEDP21.0%

TECH20.7%

EBITDA Margin (TTM)

MEDP22.0%

TECH31.6%

Net Margin (TTM)

MEDP17.7%

TECH15.0%

FCF Margin (TTM)

MEDP25.4%

TECH21.7%

Net Income (TTM)

MEDP$492M

TECH$182M

FCF (TTM)

MEDP$707M

TECH$263M

EPS (TTM)

MEDP$17.21

TECH$1.16

ROE (TTM)

MEDP110.1%

TECH8.9%

ROA (TTM)

MEDP24.8%

TECH7.1%

ROIC (TTM)

MEDP110.1%

TECH8.0%

Cash

MEDP$503M

TECH$265M

Debt

MEDP$0

TECH$200M

Net Cash/Debt

MEDP$503M

TECH$65M

Current Ratio (TTM)

MEDP0.73x

TECH4.55x

Quick Ratio (TTM)

MEDP0.66x

TECH3.35x

Debt/Equity (TTM)

MEDP0.00x

TECH0.09x

Debt/Assets (TTM)

MEDP0.0%

TECH0.0%

Interest Coverage (TTM)

MEDPN/A

TECHN/A

Net Debt/EBITDA (TTM)

MEDP0.00x

TECH0.00x

Beta

MEDP1.11

TECH1.29

52W Performance

MEDP15.3%

TECH19.6%

YTD Performance

MEDP7.2%

TECH21.5%

% from 52W High

MEDP-9.7%

TECH-0.3%

% from 52W Low

MEDP64.1%

TECH67.7%

Asset Turnover (TTM)

MEDP1.41x

TECH0.48x

FCF Yield (TTM)

MEDP4.1%

TECH2.3%

Earnings Yield (TTM)

MEDP2.9%

TECH1.6%

Dividend Yield (TTM)

MEDPN/A

TECH0.4%

Rule of 40

MEDP50.1

TECH21.3

EV/GP/RG

MEDP3.15

TECH2.28

Ticker research

View MEDP research View TECH research

Metric	MEDP Medpace Holdings Inc	TECH Bio-Techne Corp
Market & Valuation
Market Cap	$17.08B	$11.29B
Enterprise Value	$16.58B	$11.23B
Price	$612.05	$72.46
P/E Ratio	35.56x	62.64x
P/S Ratio	6.14x	9.29x
EV/Sales	5.96x	9.24x
EV/EBITDA	27.13x	28.63x
P/B Ratio	38.57x	5.39x
P/FCF Ratio	24.17x	42.89x
EV/FCF	23.46x	42.65x
PEG Ratio	2.97x	9.81x
Forward P/E (NTM)	32.69x	34.64x
Forward P/S (NTM)	5.76x	8.77x
Revenue & Growth
Revenue (TTM)	$2.78B	$1.22B
Revenue Growth (YoY)	24.7%	-0.4%
Forward Rev Growth	6.2%	9.8%
Profitability
Gross Margin (TTM)	28.8%	66.2%
Operating Margin (TTM)	21.0%	20.7%
EBITDA Margin (TTM)	22.0%	31.6%
Net Margin (TTM)	17.7%	15.0%
FCF Margin (TTM)	25.4%	21.7%
Net Income (TTM)	$492M	$182M
FCF (TTM)	$707M	$263M
EPS (TTM)	$17.21	$1.16
ROE (TTM)	110.1%	8.9%
ROA (TTM)	24.8%	7.1%
ROIC (TTM)	110.1%	8.0%
Financial Health
Cash	$503M	$265M
Debt	$0	$200M
Net Cash/Debt	$503M	$65M
Current Ratio (TTM)	0.73x	4.55x
Quick Ratio (TTM)	0.66x	3.35x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.11	1.29
52W Performance	15.3%	19.6%
YTD Performance	7.2%	21.5%
% from 52W High	-9.7%	-0.3%
% from 52W Low	64.1%	67.7%
Efficiency & Yields
Asset Turnover (TTM)	1.41x	0.48x
FCF Yield (TTM)	4.1%	2.3%
Earnings Yield (TTM)	2.9%	1.6%
Dividend Yield (TTM)	N/A	0.4%
Other
Rule of 40	50.1	21.3
EV/GP/RG	3.15	2.28
Ticker research	View MEDP research	View TECH research